glp-1 weight regain What Happens When You Stop GLP-1s — And How to Prevent Patients Who Lose Less Than

PMID: 38927090

17 In 1987, phlorizin was found to alleviate hyperglycemia and restore insulin sensitivity in rats with diabetes, indicating its potential for T2D treatment

Obesity, as a global chronic disease characterized by excessive fat accumulation, affects the health of approximately 650 million people and is associated with an increased risk of multiple metabolic complications, such as Type 2 diabetes and non-alcoholic fatty liver disease, as well as cardiovascular diseases and mechanical issues, including osteoarthritis and obstructive sleep apnea

Eat several small meals throughout the day instead of a few large ones, choose low-sugar carbs, and stay hydrated

For example, a recent market report forecasts that the global obesity drug market (fueled by GLP-1s and similar incretin therapies) could exceed $50 billion by 2030

The nuclear receptor FXR inhibits glucagon-like peptide-1 secretion in response to microbiota-derived short-chain fatty acids